2013 Fiscal Year Final Research Report
Molecular analysis of chemical chaperone effect on lysosomal storage diseases
Project/Area Number |
23591498
|
Research Category |
Grant-in-Aid for Scientific Research (C)
|
Allocation Type | Multi-year Fund |
Section | 一般 |
Research Field |
Pediatrics
|
Research Institution | Tottori University |
Principal Investigator |
HIGAKI Katsumi 鳥取大学, 生命機能研究支援センター, 准教授 (90294321)
|
Project Period (FY) |
2011 – 2013
|
Keywords | ライソゾーム病 / 脂質代謝異常 / 脳疾患 / 治療法開発 / シャペロン / 蛋白質分解 / シグナル伝達 |
Research Abstract |
I investigated the intracellular molecular mechanisms of chemical chaperone compounds to the lysosomal storage diseases. Co-crystal structural analysis of chaperone compound with lysoosmal enzyme protein identified a potent hydrogen bound in human alpha-galactosidase A protein. I also investigated the synergetic effect of the proteostasis regulator with the chaperone compound. Cultured fibroblasts analyses also found that the effect of treatment or washout of chaperone compounds on alpha-galactosidase enzyme activities as well as substrate accumulation. These results provided us important insights applicable to develop new chaperone compounds for other lysosomal diseases.
|
Research Products
(25 results)
-
[Journal Article] Targeted delivery of pharmacological chaperones for Gaucher disease to marophages by a mannosylated cyclodextrin carrier2014
Author(s)
Rodriguez-Lavado J, de la Mata M, Jimenez-Blanco J, Garcia-Moreno MI, Benito JM, Diaz-Quintana A, Sanchez-Alcazar JA, Higaki K, Nanba E, Ohno K, Suzuki Y, Ortiz Mellet C, Garcia Fernandez JM
-
Journal Title
Org Biomol Chem
Volume: 12
Pages: 2289-2301
-
-
[Journal Article] A bicyclic 1-deoxygalactonojirimycin derivative as a novel pharmacological chaperone for GM_1 gangliosidosis2013
Author(s)
Takai T, Higaki K, Aguilar-Moncayo M, Mena-Barragán T, Hirano Y, Yura K, Yu L, Ninomiya H, García-Moreno I, Sakakibara Y, Ohno K, Nanba E, Ortiz Mellet C, García Fernández JM, Suzuki Y
-
Journal Title
Mol Ther
Volume: 21
Pages: 526-532
-
-
[Journal Article] Conformationally-Locked N-Glycosides with Selectiveβ-Glycosidase Inhibitory Activity : Identification of a New Non-Iminosugar-Type Pharmacological Chaperone for Gaucher Disease2012
Author(s)
Castella J, Risquez R, Cruz D, Higaki K, Nanba E, Ohno K, Suzuki Y, Diaz Y, Ortiz Mellet C, García Fernández JM, Castellon S
-
Journal Title
J Med Chem
Volume: 55
Pages: 6857-6865
-
[Journal Article] Tuning glycosidase inhibition through aglycone interactions : Pharmacological chaperones for Fabry disease and GM1 gangliosidosis2012
Author(s)
Aguilar-Moncayo M, Takai T, Higaki K, Mena-Barragán T, Hirano Y, Yura K, Li L, Yu Y, Ninomiya H, García-Moreno MI, Ishii S, Sakakibara Y, Ohno K, Nanba E, Ortiz Mellet C, García Fernández JM, Suzuki Y
-
Journal Title
Chem Commun
Volume: 48
Pages: 6514-6516
-
[Journal Article] Therapeutic chaperone effect of N-octyl-4-epi-β-valienamine on murine GM1-gangliosidosis2012
Author(s)
Suzuki Y, Ichinomiya S, Kurosawa M, Matsuda D, Ogawa S, Iida M, Kubo T, Tabe M, Itoh M, Higaki K, Nanba E, Ohno K
-
Journal Title
Mol Genet Metab
Volume: 106
Pages: 92-98
-
[Journal Article] An"exacerbate-reverse"strategy in yeast identifies histone deacetylase inhibition as a correction for cholesterol and sphingolipid transport defects in human Niemann-Pick type C disease2011
Author(s)
Munkacsi AB, Chen FW, Brinkman MA, Higaki K, Gutiérrez GD, Chaudhari J, Layer JV, Tong A, Bard M, Boone C, Ioannou YA, Sturley SL
-
Journal Title
J Biol Chem
Volume: 286
Pages: 23842-23851
-
-
-
[Journal Article] Chemical chaperone therapy : chaperone effect on mutant enzyme and cellular pathophysiology inβ-galactosidase deficiency2011
Author(s)
Higaki K, Li L, Bahrudin U, Okuzawa S, Takamura A, Yamamoto K, Adachi K, Paraguison RC, Takai T, Ikehata H, Tominaga L, Hisatome I, Iida M, Ogawa S, Matsuda J, Ninomiya H, Sakakibara Y, Ohno K, Suzuki Y, Nanba E
-
Journal Title
Hum Mutat
Volume: 32
Pages: 843-852
-
-
-
-
-
-
-
-
-
-
-
-
-
-